CN Stock MarketDetailed Quotes

002099 Zhejiang Hisoar Pharmaceutical

Watchlist
  • 5.90
  • -0.01-0.17%
Market Closed Nov 29 15:00 CST
9.55BMarket Cap-25877P/E (TTM)

Zhejiang Hisoar Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-13.85%1.44B
-13.17%1.04B
-16.65%528.46M
-19.68%2.17B
-19.05%1.68B
-18.49%1.2B
-21.19%634.05M
8.83%2.7B
15.63%2.07B
23.46%1.47B
Operating revenue
-13.85%1.44B
-13.17%1.04B
-16.65%528.46M
-19.68%2.17B
-19.05%1.68B
-18.49%1.2B
-21.19%634.05M
8.83%2.7B
15.63%2.07B
23.46%1.47B
Other operating revenue
----
40.48%11.49M
----
43.04%9.14M
----
400.64%8.18M
----
-20.00%6.39M
----
-61.07%1.63M
Total operating cost
-17.08%1.38B
-15.07%962.35M
-29.52%452.55M
-5.77%2.33B
-7.61%1.66B
-10.89%1.13B
-9.30%642.13M
4.62%2.48B
4.42%1.8B
12.39%1.27B
Operating cost
-22.36%1.05B
-21.75%746.61M
-28.59%362.06M
-5.88%1.87B
-7.55%1.35B
-6.35%954.19M
-9.99%507.04M
27.22%1.98B
30.99%1.46B
40.12%1.02B
Operating tax surcharges
-4.01%19.64M
-6.08%12.76M
3.37%6.27M
30.47%27.76M
32.83%20.46M
28.97%13.59M
3.43%6.06M
-20.42%21.28M
-20.55%15.4M
-23.49%10.53M
Operating expense
7.77%22.61M
4.43%14.07M
10.46%5.27M
11.18%29.22M
19.54%20.98M
20.21%13.47M
-11.57%4.77M
-1.64%26.28M
-5.77%17.55M
15.41%11.2M
Administration expense
-6.86%211.6M
-0.47%144.13M
-8.14%62.69M
-19.27%324.87M
-31.65%227.19M
-33.38%144.81M
-28.00%68.24M
-29.31%402.44M
-24.12%332.41M
-25.00%217.37M
Financial expense
53.46%-25.48M
65.34%-19.44M
-155.09%-13.75M
69.44%-31.32M
61.24%-54.75M
4.34%-56.08M
547.97%24.96M
-607.29%-102.48M
-7,230.61%-141.25M
-783.86%-58.62M
-Interest expense (Financial expense)
-14.76%22.98M
4.99%18.71M
88.17%11.17M
3.33%37.76M
10.81%26.95M
2.20%17.82M
22.47%5.94M
66.99%36.55M
90.09%24.32M
59.98%17.44M
-Interest Income (Financial expense)
23.08%-44.52M
38.60%-25.55M
-105.94%-19.66M
-103.54%-68.13M
-195.84%-57.88M
-161.12%-41.61M
-141.26%-9.54M
-1.42%-33.47M
15.73%-19.57M
0.45%-15.94M
Research and development
4.74%97.7M
1.80%64.22M
-3.32%30.01M
-20.25%115.56M
-14.55%93.28M
-12.49%63.09M
-10.70%31.04M
-11.98%144.91M
-12.84%109.16M
-12.38%72.09M
Credit Impairment Loss
-84.03%3.21M
-120.22%-2.57M
-96.35%407.05K
176.54%13.41M
958.83%20.13M
333.38%12.73M
371.20%11.16M
-73.78%-17.53M
31.84%-2.34M
22.34%-5.46M
Asset Impairment Loss
---93.57M
---49.77M
---47.65M
-183.95%-237.86M
----
----
----
-676.32%-83.77M
----
----
Other net revenue
-8.37%-67.05M
9.22%-41.28M
-189.56%-46.91M
-155.65%-302.79M
-57.14%-61.87M
-4,707.11%-45.48M
1,331.18%52.38M
-2,925.45%-118.44M
-270.18%-39.37M
-93.26%987.07K
Fair value change income
100.77%336.07K
110.54%6.76M
----
-432.34%-104.25M
9.15%-43.8M
-1,365.09%-64.16M
687.33%9.26M
-402.93%-19.58M
-464.86%-48.21M
-132.01%-4.38M
Invest income
111.00%6.76M
42.43%-7.06M
-129.99%-6.03M
41.24%-13.37M
-1,670.11%-61.42M
-800.04%-12.26M
244.93%20.09M
-781.98%-22.75M
-200.16%-3.47M
555.93%1.75M
-Including: Investment income associates
20.94%-6.93M
42.47%-5.14M
-27.25%-3.87M
48.91%-16.84M
10.99%-8.77M
-30.22%-8.93M
-0.47%-3.04M
-286.34%-32.97M
-254.05%-9.85M
-189.24%-6.86M
Asset deal income
-94.43%547.93K
-96.53%365.09K
-97.21%231.69K
4,326.85%12.88M
1,926.27%9.84M
2,950.15%10.53M
5,023.79%8.3M
119.64%290.87K
1.68%485.41K
-27.67%345.32K
Other revenue
17.14%15.67M
43.20%10.99M
71.87%6.13M
6.06%26.41M
-5.54%13.38M
-12.01%7.68M
5.91%3.56M
48.68%24.9M
40.30%14.16M
33.27%8.73M
Operating profit
103.87%1.72M
96.70%35.21M
-34.52%29.01M
-524.36%-464.24M
-118.80%-44.36M
-90.93%17.9M
-55.78%44.3M
-10.36%109.4M
149.57%236.01M
173.18%197.33M
Add:Non operating Income
6,028.47%2.05M
2,933.32%1.58M
6,373.93%1.02M
-84.09%243.96K
-96.48%33.4K
-94.95%52.14K
-97.98%15.7K
-37.86%1.53M
-70.79%948.19K
-54.66%1.03M
Less:Non operating expense
-51.85%675.88K
-68.19%287.25K
-19.98%196.06K
-78.04%2.22M
32.87%1.4M
1,322.93%902.99K
96.56%245.03K
585.03%10.13M
-58.51%1.06M
-96.21%63.46K
Total profit
106.75%3.09M
114.11%36.5M
-32.32%29.83M
-562.51%-466.22M
-119.38%-45.73M
-91.40%17.05M
-56.30%44.07M
-18.07%100.8M
147.63%235.9M
172.26%198.3M
Less:Income tax cost
-14.38%-7.15M
84.27%-218.95K
-202.14%-2.27M
-403.17%-44.64M
-120.84%-6.25M
-105.06%-1.39M
-84.46%2.22M
-49.51%14.73M
51.66%29.98M
110.32%27.5M
Net profit
125.92%10.23M
99.14%36.72M
-23.30%32.1M
-589.77%-421.58M
-119.17%-39.48M
-89.20%18.44M
-51.65%41.85M
-8.30%86.08M
172.76%205.92M
185.81%170.8M
Net profit from continuing operation
125.92%10.23M
99.14%36.72M
-23.30%32.1M
-589.77%-421.58M
-119.17%-39.48M
-89.20%18.44M
-51.65%41.85M
-8.30%86.08M
172.76%205.92M
185.81%170.8M
Less:Minority Profit
-95.83%-1.75M
-88.73%-1.38M
-95.86%-495.53K
21.20%-1.53M
25.34%-891.29K
14.95%-733.19K
46.90%-253K
-42.12%-1.94M
-2.48%-1.19M
-15.35%-862.11K
Net profit of parent company owners
131.05%11.98M
98.74%38.1M
-22.58%32.59M
-577.26%-420.06M
-118.63%-38.59M
-88.83%19.17M
-51.62%42.1M
-7.58%88.01M
170.17%207.12M
183.71%171.66M
Earning per share
Basic earning per share
150.00%0.01
100.00%0.02
0.00%0.02
-620.00%-0.26
-115.38%-0.02
-90.91%0.01
-60.00%0.02
-16.67%0.05
160.00%0.13
175.00%0.11
Diluted earning per share
150.00%0.01
100.00%0.02
0.00%0.02
-620.00%-0.26
-115.38%-0.02
-90.91%0.01
-60.00%0.02
-16.67%0.05
160.00%0.13
175.00%0.11
Other composite income
-115.03%-634.72K
1,513.22%4.22M
36.40%-293.47K
Other composite income of parent company owners
----
----
----
-115.03%-634.72K
----
----
----
1,513.22%4.22M
36.40%-293.47K
----
Total composite income
125.92%10.23M
99.14%36.72M
-23.30%32.1M
-567.56%-422.22M
-119.20%-39.48M
-89.20%18.44M
-51.65%41.85M
-3.49%90.3M
174.04%205.63M
185.09%170.8M
Total composite income of parent company owners
131.05%11.98M
98.74%38.1M
-22.58%32.59M
-556.10%-420.69M
-118.66%-38.59M
-88.83%19.17M
-51.62%42.1M
-2.84%92.24M
171.42%206.82M
183.00%171.66M
Total composite income of minority owners
-95.83%-1.75M
-88.73%-1.38M
-95.86%-495.53K
21.20%-1.53M
25.34%-891.29K
14.95%-733.19K
46.90%-253K
-42.12%-1.94M
-2.48%-1.19M
-15.35%-862.11K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -13.85%1.44B-13.17%1.04B-16.65%528.46M-19.68%2.17B-19.05%1.68B-18.49%1.2B-21.19%634.05M8.83%2.7B15.63%2.07B23.46%1.47B
Operating revenue -13.85%1.44B-13.17%1.04B-16.65%528.46M-19.68%2.17B-19.05%1.68B-18.49%1.2B-21.19%634.05M8.83%2.7B15.63%2.07B23.46%1.47B
Other operating revenue ----40.48%11.49M----43.04%9.14M----400.64%8.18M-----20.00%6.39M-----61.07%1.63M
Total operating cost -17.08%1.38B-15.07%962.35M-29.52%452.55M-5.77%2.33B-7.61%1.66B-10.89%1.13B-9.30%642.13M4.62%2.48B4.42%1.8B12.39%1.27B
Operating cost -22.36%1.05B-21.75%746.61M-28.59%362.06M-5.88%1.87B-7.55%1.35B-6.35%954.19M-9.99%507.04M27.22%1.98B30.99%1.46B40.12%1.02B
Operating tax surcharges -4.01%19.64M-6.08%12.76M3.37%6.27M30.47%27.76M32.83%20.46M28.97%13.59M3.43%6.06M-20.42%21.28M-20.55%15.4M-23.49%10.53M
Operating expense 7.77%22.61M4.43%14.07M10.46%5.27M11.18%29.22M19.54%20.98M20.21%13.47M-11.57%4.77M-1.64%26.28M-5.77%17.55M15.41%11.2M
Administration expense -6.86%211.6M-0.47%144.13M-8.14%62.69M-19.27%324.87M-31.65%227.19M-33.38%144.81M-28.00%68.24M-29.31%402.44M-24.12%332.41M-25.00%217.37M
Financial expense 53.46%-25.48M65.34%-19.44M-155.09%-13.75M69.44%-31.32M61.24%-54.75M4.34%-56.08M547.97%24.96M-607.29%-102.48M-7,230.61%-141.25M-783.86%-58.62M
-Interest expense (Financial expense) -14.76%22.98M4.99%18.71M88.17%11.17M3.33%37.76M10.81%26.95M2.20%17.82M22.47%5.94M66.99%36.55M90.09%24.32M59.98%17.44M
-Interest Income (Financial expense) 23.08%-44.52M38.60%-25.55M-105.94%-19.66M-103.54%-68.13M-195.84%-57.88M-161.12%-41.61M-141.26%-9.54M-1.42%-33.47M15.73%-19.57M0.45%-15.94M
Research and development 4.74%97.7M1.80%64.22M-3.32%30.01M-20.25%115.56M-14.55%93.28M-12.49%63.09M-10.70%31.04M-11.98%144.91M-12.84%109.16M-12.38%72.09M
Credit Impairment Loss -84.03%3.21M-120.22%-2.57M-96.35%407.05K176.54%13.41M958.83%20.13M333.38%12.73M371.20%11.16M-73.78%-17.53M31.84%-2.34M22.34%-5.46M
Asset Impairment Loss ---93.57M---49.77M---47.65M-183.95%-237.86M-------------676.32%-83.77M--------
Other net revenue -8.37%-67.05M9.22%-41.28M-189.56%-46.91M-155.65%-302.79M-57.14%-61.87M-4,707.11%-45.48M1,331.18%52.38M-2,925.45%-118.44M-270.18%-39.37M-93.26%987.07K
Fair value change income 100.77%336.07K110.54%6.76M-----432.34%-104.25M9.15%-43.8M-1,365.09%-64.16M687.33%9.26M-402.93%-19.58M-464.86%-48.21M-132.01%-4.38M
Invest income 111.00%6.76M42.43%-7.06M-129.99%-6.03M41.24%-13.37M-1,670.11%-61.42M-800.04%-12.26M244.93%20.09M-781.98%-22.75M-200.16%-3.47M555.93%1.75M
-Including: Investment income associates 20.94%-6.93M42.47%-5.14M-27.25%-3.87M48.91%-16.84M10.99%-8.77M-30.22%-8.93M-0.47%-3.04M-286.34%-32.97M-254.05%-9.85M-189.24%-6.86M
Asset deal income -94.43%547.93K-96.53%365.09K-97.21%231.69K4,326.85%12.88M1,926.27%9.84M2,950.15%10.53M5,023.79%8.3M119.64%290.87K1.68%485.41K-27.67%345.32K
Other revenue 17.14%15.67M43.20%10.99M71.87%6.13M6.06%26.41M-5.54%13.38M-12.01%7.68M5.91%3.56M48.68%24.9M40.30%14.16M33.27%8.73M
Operating profit 103.87%1.72M96.70%35.21M-34.52%29.01M-524.36%-464.24M-118.80%-44.36M-90.93%17.9M-55.78%44.3M-10.36%109.4M149.57%236.01M173.18%197.33M
Add:Non operating Income 6,028.47%2.05M2,933.32%1.58M6,373.93%1.02M-84.09%243.96K-96.48%33.4K-94.95%52.14K-97.98%15.7K-37.86%1.53M-70.79%948.19K-54.66%1.03M
Less:Non operating expense -51.85%675.88K-68.19%287.25K-19.98%196.06K-78.04%2.22M32.87%1.4M1,322.93%902.99K96.56%245.03K585.03%10.13M-58.51%1.06M-96.21%63.46K
Total profit 106.75%3.09M114.11%36.5M-32.32%29.83M-562.51%-466.22M-119.38%-45.73M-91.40%17.05M-56.30%44.07M-18.07%100.8M147.63%235.9M172.26%198.3M
Less:Income tax cost -14.38%-7.15M84.27%-218.95K-202.14%-2.27M-403.17%-44.64M-120.84%-6.25M-105.06%-1.39M-84.46%2.22M-49.51%14.73M51.66%29.98M110.32%27.5M
Net profit 125.92%10.23M99.14%36.72M-23.30%32.1M-589.77%-421.58M-119.17%-39.48M-89.20%18.44M-51.65%41.85M-8.30%86.08M172.76%205.92M185.81%170.8M
Net profit from continuing operation 125.92%10.23M99.14%36.72M-23.30%32.1M-589.77%-421.58M-119.17%-39.48M-89.20%18.44M-51.65%41.85M-8.30%86.08M172.76%205.92M185.81%170.8M
Less:Minority Profit -95.83%-1.75M-88.73%-1.38M-95.86%-495.53K21.20%-1.53M25.34%-891.29K14.95%-733.19K46.90%-253K-42.12%-1.94M-2.48%-1.19M-15.35%-862.11K
Net profit of parent company owners 131.05%11.98M98.74%38.1M-22.58%32.59M-577.26%-420.06M-118.63%-38.59M-88.83%19.17M-51.62%42.1M-7.58%88.01M170.17%207.12M183.71%171.66M
Earning per share
Basic earning per share 150.00%0.01100.00%0.020.00%0.02-620.00%-0.26-115.38%-0.02-90.91%0.01-60.00%0.02-16.67%0.05160.00%0.13175.00%0.11
Diluted earning per share 150.00%0.01100.00%0.020.00%0.02-620.00%-0.26-115.38%-0.02-90.91%0.01-60.00%0.02-16.67%0.05160.00%0.13175.00%0.11
Other composite income -115.03%-634.72K1,513.22%4.22M36.40%-293.47K
Other composite income of parent company owners -------------115.03%-634.72K------------1,513.22%4.22M36.40%-293.47K----
Total composite income 125.92%10.23M99.14%36.72M-23.30%32.1M-567.56%-422.22M-119.20%-39.48M-89.20%18.44M-51.65%41.85M-3.49%90.3M174.04%205.63M185.09%170.8M
Total composite income of parent company owners 131.05%11.98M98.74%38.1M-22.58%32.59M-556.10%-420.69M-118.66%-38.59M-88.83%19.17M-51.62%42.1M-2.84%92.24M171.42%206.82M183.00%171.66M
Total composite income of minority owners -95.83%-1.75M-88.73%-1.38M-95.86%-495.53K21.20%-1.53M25.34%-891.29K14.95%-733.19K46.90%-253K-42.12%-1.94M-2.48%-1.19M-15.35%-862.11K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data